VF
REVBW icon

Virtu Financial’s Revelation Biosciences Warrant REVBW Stock Holding History

Virtu Financial’s Portfolio REVBW Stock Details REVBW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$0 Buy
+50,463
New +$525 ﹤0.01% 2138
2023
Q2 		– Sell
-29,616
Closed – – 1950
2023
Q1 		$0 Buy
+29,616
New +$743 ﹤0.01% 2001
2022
Q2 		– Sell
-29,935
Closed -$4K – 1987
2022
Q1 		$4K Buy
+29,935
New +$7.64K ﹤0.01% 1400

Other funds holding REVBW

LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
PVI
Pine Valley Investments Marlton, New Jersey $2.53B AUM 36.18% 1-Year Est. Return
TC
T3 Companies New York $93.7M AUM
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
SIA
Soltis Investment Advisors St. George, Utah $1.8B AUM 27.41% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Virtu Financial's REVBW Position: Q2 2026 in Review

Virtu Financial opened a new position in Revelation Biosciences Warrant (REVBW) in Q2 2026: 50,463 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #2138 among its holdings. This is a return to the name: Virtu Financial previously reported a position in REVBW as recently as Q1 2023.

Virtu Financial first reported a position in REVBW in Q1 2022 and has held it in 3 quarters since. The position peaked at $4K in Q1 2022. 13 funds tracked by Wall St. Rank hold REVBW as of Q2 2026.

  • Virtu Financial held 50,463 shares of Revelation Biosciences Warrant worth $0 as of Q2 2026.
  • Revelation Biosciences Warrant was a new Virtu Financial position in Q2 2026.
  • Revelation Biosciences Warrant made up ﹤0.01% of Virtu Financial's portfolio in Q2 2026, its #2138 holding.
  • Virtu Financial first reported a position in Revelation Biosciences Warrant in Q1 2022 and has held it in 3 quarters since.
  • Virtu Financial's Revelation Biosciences Warrant position peaked at $4K in Q1 2022.
  • 13 funds tracked by Wall St. Rank held Revelation Biosciences Warrant as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.